Identifying factors associated with clinical success in patients treated with NASHA(®)/Dx injection for fecal incontinence

por Franklin, Howard, Barrett, Andrew C, Wolf, Ray
Publicado 2016

Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis

por Viscusi, Eugene R., Barrett, Andrew C., Paterson, Craig, Forbes, William P.
Publicado 2016

Dose Proportionality and Steady-State Pharmacokinetics of Serdexmethylphenidate/Dexmethylphenidate, a Novel Prodrug Combination to Treat Attention-Deficit/Hyperactivity Disorder

por Braeckman, Rene, Guenther, Sven, Mickle, Travis C., Barrett, Andrew C., Smith, Adam, Oh, Charles
Publicado 2022

Validity of the ≥50% Response Threshold in Treatment With NASHA/Dx Injection Therapy for Fecal Incontinence

por Sanchez, Jaime E, Brenner, Darren M, Franklin, Howard, Yu, Jing, Barrett, Andrew C, Paterson, Craig
Publicado 2015

Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extensi...

por Bull, Janet, Wellman, Charles V., Israel, Robert J., Barrett, Andrew C., Paterson, Craig, Forbes, William P.
Publicado 2015

Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain

por Webster, Lynn R, Brenner, Darren M, Barrett, Andrew C, Paterson, Craig, Bortey, Enoch, Forbes, William P
Publicado 2015

Relative Bioavailability, Intranasal Abuse Potential, and Safety of Benzhydrocodone/Acetaminophen Compared with Hydrocodone Bitartrate/Acetaminophen in Recreational Drug Abusers

por Guenther, Sven M, Mickle, Travis C, Barrett, Andrew C, Roupe, Kathryn Ann, Zhou, Jing, Lam, Vincent
Publicado 2018

Pharmacokinetics and Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone, After Intranasal Administration in Recreational Drug Users

por Mickle, Travis C, Guenther, Sven M, Barrett, Andrew C, Roupe, Kathryn Ann, Zhou, Jing, Dickerson, Daniel, Webster, Lynn R
Publicado 2018

Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission

por Lichtenstein, Gary R., Gordon, Glenn L., Zakko, Salam, Murthy, Uma, Sedghi, Shahriar, Pruitt, Ron, Barrett, Andrew C., Bortey, Enoch, Paterson, Craig, Forbes, William P.
Publicado 2015

Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial

por Rubin, David T., Cohen, Russell D., Sandborn, William J., Lichtenstein, Gary R., Axler, Jeffrey, Riddell, Robert H., Zhu, Cindy, Barrett, Andrew C., Bortey, Enoch, Forbes, William P.
Publicado 2017

Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial

por Rubin, David T, Cohen, Russell D, Sandborn, William J, Lichtenstein, Gary R, Axler, Jeffrey, Riddell, Robert H, Zhu, Cindy, Barrett, Andrew C, Bortey, Enoch, Forbes, William P
Publicado 2017

Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis

por Rubin, David T., Sandborn, William J., Bosworth, Brian, Zakko, Salam, Gordon, Glenn L., Sale, Mark E., Rolleri, Robert L., Golden, Pamela L., Barrett, Andrew C., Bortey, Enoch, Forbes, William P.
Publicado 2015